Vir Biotechnology (VIR) Current Assets (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Current Assets data on file, last reported at $523.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 43.9% year-over-year to $523.0 million; the trailing twelve-month figure through Mar 2026 stood at $523.0 million (down 43.9% YoY), and the FY2025 full-year result was $514.1 million, down 50.69% from the prior year.
• Current Assets rose to $523.0 million in Q1 2026, from $514.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.6 billion in Q1 2022 to a low of $514.1 million in Q4 2025.
• A 5-year average of $1.5 billion and a median of $1.2 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 165.37% in 2022 and plunged 50.69% in 2025, its largest moves.
• Tracing VIR's Current Assets over 5 years: stood at $2.5 billion in 2022, then tumbled by 36.95% to $1.6 billion in 2023, then tumbled by 34.36% to $1.0 billion in 2024, then sank by 50.69% to $514.1 million in 2025, then climbed by 1.73% to $523.0 million in 2026.
• Business Quant data shows VIR's Current Assets at $523.0 million in Q1 2026, $514.1 million in Q4 2025, and $545.7 million in Q3 2025.